Jinghua Weikang capsule for <i>helicobacter pylori</i> eradication: A systematic review and meta-analysis with trial sequential analysis.

Jinghua Weikang capsule for helicobacter pylori eradication: A systematic review and meta-analysis with trial sequential analysis.

Zhao, Qian; Wang, Wen-Jia; Zhou, Shui-Ping; Su, Jing; Sun, He; Zhai, Jing-Bo; Hu, Yun-Hui.

Affiliation

Zhao Q; Cloudphar Pharmaceuticals Co, Ltd., Shenzhen, China.
Wang WJ; Cloudphar Pharmaceuticals Co, Ltd., Shenzhen, China.
Zhou SP; The State Key Laboratory of Core Technology in Innovative Chinese Medicine, Tasly Academy, Tasly Holding Group Co, Ltd., Tianjin, China.
Su J; Tasly Pharmaceutical Group Co, Ltd., Tianjin, China.
Sun H; Tasly Pharmaceutical Group Co, Ltd., Tianjin, China.
Zhai JB; The State Key Laboratory of Core Technology in Innovative Chinese Medicine, Tasly Academy, Tasly Holding Group Co, Ltd., Tianjin, China.
Hu YH; Tasly Pharmaceutical Group Co, Ltd., Tianjin, China.

Front Pharmacol ; 13: 959184, 2022.

Article in En | MEDLINE | ID: mdl-36225593